Newsletter

Familial Chylomicronemia Syndrome
A rare burdensome disorder, Familial chylomicronemia syndrome that does not shy away from affecting generations
Familial Chylomicronemia Syndrome

More Whitepapers / Newsletters

The Ophthalmic Drug Delivery Therapeutics For Retinal Disorders Whitepaper
The Ophthalmic Drug Delivery T...

Delivery of therapeutics to the human eye is among the most interesting endeavours a formulator can take on, but also one of the most challenging. The anatomy and chemical make-up of the eye make it h...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...

Digital Therapeutics In Mental Health Whitepaper
Digital Therapeutics In Mental...

Digital therapies are evidence-based clinical approaches powered by software applications designed to prevent, control or treat a particular disease or condition. While advances in technology-assisted...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD), characterized by fibrosis and worsening lung function. It majorly affects the population older of...